Our Mission to Transform
Patient Lives
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells. Our investigational off-the-shelf T‑Cells are intended for rapid delivery from inventory to patients.
Our Mission
Transform the lives of patients with serious medical conditions through pioneering science, teamwork and a commitment to excellence
Our Proprietary T-Cell Immunotherapy Technology Platform
Our unique platform is to create off-the-shelf, allogeneic T-cell libraries that can be used to select the appropriate cells for a patient's unique immune profile.
View TechnologyOur Pipeline
Our robust pipeline features multiple T-cell immunotherapies in clinical and pre-clinical development
Tab-cel® (tabelecleucel)
T-cell immunotherapy for EBV-associated ultra-rare diseases
FDA breakthrough designation & EMA PRIME for EBV+ PTLD
ATA188
EBV T-cell immunotherapy for progressive multiple sclerosis (MS)ATA2271/ATA3271
Mesothelin CAR T for solid tumorsPatient Stories
Doug
Ayden
Jessica
Ola
Patient Stories
“I learned how to cultivate wonder about life’s simple moments because I didn’t know how many moments I had left.”Doug
Patient Stories
“Don’t give up. That’s the main thing.”Ayden
Patient Stories
“I have always been very aware of the preciousness of life and that it is something we cannot take for granted.”Jessica
Patient Stories
“I am who I am because of my disability. People read my story and say, ‘You are a role model to me.’ Hearing that from others is what drives me forward.”Ola